| # | % | |||||
|---|---|---|---|---|---|---|
| 251 | ACADIA PHARMACEUTICALS INC COM | 21,333 | 705,000 | 0.01% | ||
| 252 | CONATUS PHARMACEUTICALS INC | 156,531 | 695,000 | 0.01% | ||
| 253 | TOBIRA THERAPEUTICS INC | 67,570 | 653,000 | 0.01% | ||
| 254 | Meta Finl Group Inc | 15,574 | 651,000 | 0.01% | ||
| 255 | CALAMP CORP | 40,200 | 647,000 | 0.01% | ||
| 256 | PACIRA PHARMACEUTICALS INC | 14,890 | 612,000 | 0.01% | ||
| 257 | SYNERGY PHARMACEUTICALS DEL | 114,530 | 607,000 | 0.01% | ||
| 258 | OPHTHOTECH CORP | 14,316 | 580,000 | 0.01% | ||
| 259 | MODEL N INCORPORATED | 57,651 | 576,000 | 0.01% | ||
| 260 | MEDIVATION INC | 13,141 | 558,000 | 0.01% | ||
| 261 | ProQR Therapeutics NV | 35,000 | 510,000 | 0.01% | ||
| 262 | INOTEK PHARMACEUTICALS CORP | 49,912 | 469,000 | 0.01% | ||
| 263 | SVB FINANCIAL GROUP | 3,774 | 436,000 | 0.01% | ||
| 264 | ALKERMES PLC | 7,134 | 419,000 | 0.01% | ||
| 265 | PROSPERITY BANCSHARES INC | 8,272 | 406,000 | 0.01% | ||
| 266 | QIWI PLC | 17,317 | 279,000 | 0.01% | ||
| 267 | AFFIMED N V COM | 43,550 | 269,000 | 0.01% | ||
| 268 | WISDOMTREE INVTS INC | 14,950 | 241,000 | 0.00% | ||
| 269 | NET 1 UEPS TECHNOLOGIES INC | 14,293 | 239,000 | 0.00% | ||
| 270 | VITAE PHARMACEUTICALS INC | 19,011 | 209,000 | 0.00% | ||
| 271 | FLUIDIGM CORP DEL COM | 24,095 | 195,000 | 0.00% | ||
| 272 | VERMILLION INC | 26,463 | 53,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-15-002012, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
